WO2004019885A3 - Delivrance sous forme de film a dissolution rapide de nucleotides inhibant le gout desagreable de medicaments au gout amer - Google Patents

Delivrance sous forme de film a dissolution rapide de nucleotides inhibant le gout desagreable de medicaments au gout amer Download PDF

Info

Publication number
WO2004019885A3
WO2004019885A3 PCT/US2003/027111 US0327111W WO2004019885A3 WO 2004019885 A3 WO2004019885 A3 WO 2004019885A3 US 0327111 W US0327111 W US 0327111W WO 2004019885 A3 WO2004019885 A3 WO 2004019885A3
Authority
WO
WIPO (PCT)
Prior art keywords
inhibit
medications
nucleotides
bitter tasting
unpleasant taste
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/027111
Other languages
English (en)
Other versions
WO2004019885A2 (fr
Inventor
Richard Alexander Mcgregor
Harvey Donald Homan
Stephen Anthony Gravina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Linguagen Corp
Original Assignee
Linguagen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Linguagen Corp filed Critical Linguagen Corp
Priority to AU2003268262A priority Critical patent/AU2003268262A1/en
Publication of WO2004019885A2 publication Critical patent/WO2004019885A2/fr
Publication of WO2004019885A3 publication Critical patent/WO2004019885A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0015—Devices specially adapted for taking medicines
    • A61J7/0046—Cups, bottles or bags
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/79—Fixation, conservation, or encapsulation of flavouring agents in the form of films
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/86—Addition of bitterness inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0015—Devices specially adapted for taking medicines
    • A61J7/0061—Swallow helping devices, e.g. tongue shields
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
    • A61J7/0092—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine for holding medicines in, or fixing medicines on, a tooth, e.g. holder containing medicines fixed on a tooth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Physiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention a trait à des films physiologiquement acceptables, y compris des films comestibles. Ces films comprennent un polymère filmogène hydrosoluble tel que le pullulane. L'invention a trait à des films comestibles comprenant du pullulane et une quantité efficace d'un ou de plusieurs composés nucléotidiques qui contient un groupe purique ou pyrimidique ou un dérivé de ceux-ci qui inhibent l'activation de la perception sensorielle de la protéine G du goût amer de médicaments au goût amer.
PCT/US2003/027111 2002-08-29 2003-08-28 Delivrance sous forme de film a dissolution rapide de nucleotides inhibant le gout desagreable de medicaments au gout amer Ceased WO2004019885A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003268262A AU2003268262A1 (en) 2002-08-29 2003-08-28 Fast dissolving film delivery of nucleotides that inhibit the unpleasant taste of bitter tasting medications

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40671602P 2002-08-29 2002-08-29
US60/406,716 2002-08-29

Publications (2)

Publication Number Publication Date
WO2004019885A2 WO2004019885A2 (fr) 2004-03-11
WO2004019885A3 true WO2004019885A3 (fr) 2004-09-10

Family

ID=31978346

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/027111 Ceased WO2004019885A2 (fr) 2002-08-29 2003-08-28 Delivrance sous forme de film a dissolution rapide de nucleotides inhibant le gout desagreable de medicaments au gout amer

Country Status (2)

Country Link
AU (1) AU2003268262A1 (fr)
WO (1) WO2004019885A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2815367C1 (ru) * 2023-05-03 2024-03-13 Валентина Владимировна Потапова Биокомпозиционный материал на основе природных полисахаридов

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
BRPI0415741B1 (pt) 2003-11-07 2013-07-23 composições de tabaco e métodos de fabricação de uma composição de tabaco
US20070059421A1 (en) * 2005-09-13 2007-03-15 Catani Steven J Methods and compositions to improve the palatability of foods
US20080220029A1 (en) * 2007-03-05 2008-09-11 Charlene Ng Fast-dissolving/disintegrating film preparation having high proportion of active
DE102010049708A1 (de) 2010-10-28 2012-05-03 Hexal Ag Orale pharmazeutische Filmformulierung für bitter schmeckende Arzneistoffe
US9648874B2 (en) 2010-12-07 2017-05-16 Kimberly-Clark Worldwide, Inc. Natural, multiple use and re-use, user saturated wipes
EP2701534A1 (fr) * 2011-04-28 2014-03-05 ACME Specialty Products, LLC Compositions de masquage du goût et leurs formes comestibles
US8574628B2 (en) * 2011-12-19 2013-11-05 Kimberly-Clark Worldwide, Inc. Natural, multiple release and re-use compositions
JP6574556B2 (ja) * 2014-08-27 2019-09-11 日東電工株式会社 口腔内フィルム状基剤及び製剤
CN105193769B (zh) * 2015-09-06 2019-02-05 合肥华方医药科技有限公司 一种盐酸苯海拉明口腔速溶膜剂的制备方法
US11040103B2 (en) * 2016-04-15 2021-06-22 Admbioscience Inc. Method for manufacturing nucleic acid film and apparatus for injecting medicine using nucleic acid film
AU2018239993B2 (en) * 2017-03-20 2024-01-25 Bayer Healthcare Llc Chewable gel products for active pharmaceutical ingredients
US10537519B2 (en) * 2017-08-16 2020-01-21 Sci-Chem International Pty Ltd Compositions for treating infections
WO2020226889A1 (fr) * 2019-05-07 2020-11-12 Wellstat Therapeutics Corporation Formulations d'uridine triacétate dans de la triacétine
EP4247331B1 (fr) 2020-11-18 2025-10-08 BioPharma Synergies, S. L. Composition de poudre orodispersible comprenant un composé antihistaminique

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5518902A (en) * 1992-08-20 1996-05-21 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo High pullulan content product, and its preparation and uses

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5518902A (en) * 1992-08-20 1996-05-21 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo High pullulan content product, and its preparation and uses

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2815367C1 (ru) * 2023-05-03 2024-03-13 Валентина Владимировна Потапова Биокомпозиционный материал на основе природных полисахаридов

Also Published As

Publication number Publication date
AU2003268262A1 (en) 2004-03-19
WO2004019885A2 (fr) 2004-03-11
AU2003268262A8 (en) 2004-03-19

Similar Documents

Publication Publication Date Title
WO2004019885A3 (fr) Delivrance sous forme de film a dissolution rapide de nucleotides inhibant le gout desagreable de medicaments au gout amer
WO2004089336A3 (fr) Systemes d'administration de medicaments contenant un principe actif mis en gelule
IL168266A (en) Nucleoside derivatives, processes for their preparation. pharmaceutical compositions comprising them and uses thereof for the manufacture of medicaments
AU2003280087A1 (en) Dosage forms for increasing the solubility and extending the release of drugs such as e.g. topiramate and phenyton
WO2003041755A3 (fr) Film pour dispositifs d'apport de medicament
WO2006060547A3 (fr) Systemes et methodes d'administration intra-orale de medicaments
AU2003222666A1 (en) Implantable drug delivery system responsive to intra-cardiac pressure
WO2004006858A3 (fr) Composes, compositions et methodes d'utilisation de ces derniers
FR11C0017I1 (fr)
WO2001068034A3 (fr) Promedicaments antiviraux
WO2006124366A3 (fr) Aromatisant pour chewing gums contenant un medicament
WO2005065318A3 (fr) Formes galeniques d'opiates orales effervescentes et procedes d'administration d'opiates
WO2005018555A3 (fr) Modificateurs de la reponse immunitaire a modification lipidique
AU2003300202A1 (en) Drug delivery balloon catheter
WO2005004989A3 (fr) Film renfermant des agents therapeutiques
WO2008085765A3 (fr) Formes dosifiées de petit volume de médicament contenant du sufentanil s'administrant par voie trans-muqueuse orale pour le traitement de la douleur
WO2004074232A8 (fr) Derives d'acide 1-phenylalcane-carboxylique pour le traitement de maladies neurodegeneratives
WO2005005414A3 (fr) Derives de pyrazolyl-indole actifs en tant qu'inhibiteurs de kinase, procede de preparation correspondant et compositions pharmaceutiques les contenant
WO2004050040A3 (fr) Composition pharmaceutique de 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5h-2,3-benzodiazepine et utilisations
WO2002047607A3 (fr) Procede de preparation d'une forme posologique rapidement soluble
AU2003211238A1 (en) Drug delivery system for the subconjunctival administration of fine grains
WO2004069146A3 (fr) Derives d'amide l-dopa et utilisations de ceux-ci
WO2003090696A3 (fr) Procede et produits pour administration par voie muqueuse
BRPI0513455A (pt) formulação para mascaramento de sabor compreendendo o fármaco em uma forma de dissolução retardada e/ou ciclodextrina em uma forma de dissolução melhorada
WO2005014572A8 (fr) Derives de pyrimidylpyrrole pouvant etre utilises comme inhibiteurs de kinases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP